Obesity Treatment
-
{
- All
- News
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
Drugs Or Surgery For Obesity? Doctor Explains When That Becomes The Wrong Question
Bariatric surgery works by mechanisms that go far beyond reducing the volume of the stomach. These procedures, like sleeve gastrectomy and gastric bypass, change gut hormones, improve the body's sensitivity to insulin, alter appetite regulation and modify the body's metabolic response to food.
-
Taking A Break? Study Finds Why Many GLP-1 Users Stop And Restart Their Medication
The findings provide insight into the challenges people face while using these medications and may help healthcare providers identify patients who need support to stay on treatment.
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
How Brown Fat Turns Fuel Into Heat: Study Finds The Protein Behind The Process
The new findings, including how SLIT3 splits into two parts and interacts with receptors to shape nerve and blood vessel networks, point to several potential targets for future treatments.
-
How Python Blood Molecule Could Help Fight Obesity, Scientists Say
A molecule found in python blood has shown the ability to reduce appetite and promote weight loss in mice, offering potential for new obesity treatments.
-
Maharashtra Doctor Shares How A Couple Lost 7 Kg In 76 Days
The couple ate home-cooked meals, walked 30-40 minutes a day, avoided refined carbohydrates, and prioritised protein
-
Obesity In Teenagers: Here's Why Early Intervention Is Crucial
Obese children are highly likely to remain obese as adults, creating a lifelong cycle of illness. If obesity persists into adulthood, the risk of chronic diseases and related health problems increases significantly.
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
How Intermittent Fasting Boosts Weight Loss And Heart Health In People With Obesity
A study highlights the benefits of intermittent fasting for individuals with obesity, showing it can promote weight loss and improve heart health.
-
Weight Loss: Obesity And Binge Eating May Be Treated By Understanding Personality Disorders; Says Study
The study claims that an individual's personality and psychological features can also play a noteworthy role in weight gain.
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
Drugs Or Surgery For Obesity? Doctor Explains When That Becomes The Wrong Question
Bariatric surgery works by mechanisms that go far beyond reducing the volume of the stomach. These procedures, like sleeve gastrectomy and gastric bypass, change gut hormones, improve the body's sensitivity to insulin, alter appetite regulation and modify the body's metabolic response to food.
-
Taking A Break? Study Finds Why Many GLP-1 Users Stop And Restart Their Medication
The findings provide insight into the challenges people face while using these medications and may help healthcare providers identify patients who need support to stay on treatment.
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
How Brown Fat Turns Fuel Into Heat: Study Finds The Protein Behind The Process
The new findings, including how SLIT3 splits into two parts and interacts with receptors to shape nerve and blood vessel networks, point to several potential targets for future treatments.
-
How Python Blood Molecule Could Help Fight Obesity, Scientists Say
A molecule found in python blood has shown the ability to reduce appetite and promote weight loss in mice, offering potential for new obesity treatments.
-
Maharashtra Doctor Shares How A Couple Lost 7 Kg In 76 Days
The couple ate home-cooked meals, walked 30-40 minutes a day, avoided refined carbohydrates, and prioritised protein
-
Obesity In Teenagers: Here's Why Early Intervention Is Crucial
Obese children are highly likely to remain obese as adults, creating a lifelong cycle of illness. If obesity persists into adulthood, the risk of chronic diseases and related health problems increases significantly.
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
How Intermittent Fasting Boosts Weight Loss And Heart Health In People With Obesity
A study highlights the benefits of intermittent fasting for individuals with obesity, showing it can promote weight loss and improve heart health.
-
Weight Loss: Obesity And Binge Eating May Be Treated By Understanding Personality Disorders; Says Study
The study claims that an individual's personality and psychological features can also play a noteworthy role in weight gain.
